Journal
CANCER LETTERS
Volume 419, Issue -, Pages 27-29Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2018.01.008
Keywords
Cytoplasmic IncRNA; Lipid; ceRNA; Cancer; Signaling pathway
Categories
Funding
- National Science Foundation of China [81672791]
- Zhejiang Province Natural Science Foundation of China [LY13H100001, LY15C080001]
- Zhejiang Provincial Natural Science Fund for Distinguished Young Scholars of China [LR18C060002]
Ask authors/readers for more resources
Long noncoding RNAs (LncRNAs) are one of the emerging regulators which are involved in diverse biological processes. LncRNAs can participate in the regulation of gene expression via various ways in the cytoplasm and the nucleus. The function of the nuclear LncRNAs has been studied a lot. Recent studies have shown that the regulatory roles of cytoplasmic IncRNA, including membrane lipid associated IncRNA, which may open an unexplored mechanistic territory. LncRNA dysregulated expression represents a common event in pathogenesis of a variety of human genetic diseases including cancer. Lipid associated IncRNA is capable of modulating critical cellular functions by directly interacting with phospholipids on the plasma membrane. Besides, it also could be a predictor for the poor prognosis of cancer. In this review, we sum up the roles of cytoplasmic IncRNA, especially lipid-associated IncRNA in cancer. (C) 2018 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available